References
- American College of Obstetricians Gynecologists. ACOG Committee opinion no. 444: choosing the route of hysterectomy for benign disease. Obstet Gynecol 2009;114:1156
- Whiteman MK, Hillis SD, Jamieson DJ, et al. Inpatient hysterectomy surveillance in the United States, 2000–2004. Am J Obstet Gynecol 2008;198:34.e1-7
- Gliklich RE, Leavy MB, Velentgas P, et al. Identification of future research needs in the comparative management of uterine fibroid disease. A report on the priority-setting process, preliminary data analysis, and research plan. Effective Healthcare Research Report No. 31. AHRQ Publication No. 11- EHC023-EF. Rockville, MD: Agency for Healthcare Research and Quality. March 2011. Available at: http://effectivehealthcare.ahrq.gov/reports/final.cfm Accessed: 13 November 2014
- Gretz H, Bradley WH, Zakashansky K, et al. Patient clinical factors influencing use of hysterectomy in New York, 2001–2005. Obstet Gynecol Surv 2009;64:22-3
- Keshavarz H, Hillis SD, Kieke BA, Marchbanks PA. Hysterectomy surveillance – United States, 1994–1999. MMWR CDC Surveill Summ 2002;51:1-8
- Parker WH. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 2007;87:725-36
- Baird DD, Dunson DB, Hill MC, et al. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 2003;188:100-7
- Zimmermann A, Bernuit D, Gerlinger C, et al. Prevalence, symptoms and management of uterine fibroids: an international internet-based survey of 21,746 women. BMC Womens Health 2012;12:6
- Cardozo ER, Clark AD, Banks NK, et al. The estimated annual cost of uterine leiomyomata in the United States. Am J Obstet Gynecol 2012;206:211.e1-9
- National Uterine Fibroids Foundation. Uterine fibroids – Introduction. Colorado Springs, CO: National Uterine Fibroids Foundation, 2010. Available at: http://www.nuff.org/health.htm [Last accessed 13 November 2014]
- Deal LS, Williams VS, Fehnel SE. Development of an electronic daily uterine fibroid symptom diary. Patient 2011;4:31-44
- Dragomir AD, Schroeder JC, Connolly A, et al. Uterine leiomyomata associated with self-reported stress urinary incontinence. J Womens Health (Larchmt) 2010;19:245-50
- Hildreth CJ, Lynm C, Glass RM. JAMA patient page. Uterine fibroids. JAMA 2009;301:122
- Barlow D, Oliver J, Loumaye E. P-220 Women with uterine fibroids have high levels of pain and substantially impaired Quality of Life (qol). Hum Reprod 2011;26(suppl_1):i208-i09
- Borah BJ, Nicholson WK, Bradley L, Stewart EA. The impact of uterine leiomyomas: a national survey of affected women. Am J Obstet Gynecol 2013;209:319.e1-20
- Downes E, Sikirica V, Gilabert-Estelles J, et al. The burden of uterine fibroids in five European countries. Eur J Obstet Gynecol Reprod Biol 2010;152:96-102
- Lee DW, Ozminkowski RJ, Carls GS, et al. The direct and indirect cost burden of clinically significant and symptomatic uterine fibroids. J Occup Environ Med 2007;49:493-506
- Ghant M, Lawson A, Sengoba K, et al. Beyond the physical: a qualitative assessment of the emotional burden of symptomatic uterine fibroids on women’s mental health. Fertil Steril 2014;102:e248
- Pron G, Cohen M, Soucie J, et al. The Ontario Uterine Fibroid Embolization Trial. Part 1. Baseline patient characteristics, fibroid burden, and impact on life. Fertil Steril 2003;79:112-19
- Rowe MK, Kanouse DE, Mittman BS, Bernstein SJ. Quality of life among women undergoing hysterectomies. Obstet Gynecol 1999;93:915-21
- Spies JB, Warren EH, Mathias SD, et al. Uterine fibroid embolization: measurement of health-related quality of life before and after therapy. J Vasc Interv Radiol 1999;10:1293-303
- Fuldeore MJ, Soliman AM. Prevalence and Symptomatic Burden of Diagnosed Endometriosis in the United States: National Estimates from a Cross-Sectional Survey of 59,411 Women. Gynecol Obstet Invest 2017;82:453-461
- Soliman AM, Coyne KS, Zaiser E, et al. The burden of endometriosis symptoms on health-related quality of life in women in the United States: a cross-sectional study. J Psychosomatic Obstet Gynecol 2017:1-11
- Kalton G, Flores-Cervantes I. Weighting methods. J Off Stat 2003;19:81-97
- Coyne KS, Soliman AM, Margolis MK, et al. Validation of the 4 week recall version of the Uterine Fibroid Symptom and Health-related Quality of Life (UFS-QOL) Questionnaire. Curr Med Res Opin 2017;33:193-200
- Spies JB, Coyne K, Guaou Guaou N, et al. The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 2002;99:290-300
- Coyne KS, Margolis MK, Bradley LD, et al. Further validation of the uterine fibroid symptom and quality-of-life questionnaire. Value Health 2012;15:135-42
- Lippman SA, Warner M, Samuels S, et al. Uterine fibroids and gynecologic pain symptoms in a population-based study. Fertil Steril 2003;80:1488-94
- Stewart EA, Nicholson WK, Bradley L, Borah BJ. The burden of uterine fibroids for African-American women: results of a national survey. J Womens Health 2013;22:807-16
- Moorman PG, Leppert P, Myers ER, Wang F. Comparison of characteristics of fibroids in African American and white women undergoing premenopausal hysterectomy. Fertil Steril 2013;99:768-76 e1
- Biglia N, Carinelli S, Maiorana A, et al. Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids. Drug Des Devel Ther 2014;8:285
- Donnez J, Dolmans M-M. Uterine fibroid management: from the present to the future. Hum Reprod Update 2016;22:665-86